Overview

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
A new paediatric formulation (oral liquid) has been developed for flexible and accurate dosing of valacyclovir in children. To establish the bioavailability of this new formulation, healthy volunteers will be exposed to the new formulation and to valacyclovir tablets. The concentration of valacyclovir in their blood after exposure to the oral liquid will be measured and compared to the tablet.
Phase:
Phase 1
Details
Lead Sponsor:
Radboud University
Treatments:
Acyclovir
Valacyclovir